95 related articles for article (PubMed ID: 12699249)
1. Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Hinnen P; Siersema PD; Edixhoven A; Wilson JH; de Rooij FW
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):903-9. PubMed ID: 12699249
[TBL] [Abstract][Full Text] [Related]
2. Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Hinnen P; de Rooij FW; Terlouw EM; Edixhoven A; van Dekken H; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 2000 Aug; 83(4):539-43. PubMed ID: 10945504
[TBL] [Abstract][Full Text] [Related]
3. Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Hinnen P; de Rooij FW; van Velthuysen ML; Edixhoven A; van Hillegersberg R; Tilanus HW; Wilson JH; Siersema PD
Br J Cancer; 1998 Sep; 78(5):679-82. PubMed ID: 9744510
[TBL] [Abstract][Full Text] [Related]
4. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
6. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
van den Boogert J; van Staveren HJ; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Med Sci; 2001; 16(1):16-25. PubMed ID: 11486333
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
8. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
12. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW
Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
14. The centrality of PBGD expression levels on ALA-PDT efficacy.
Schauder A; Feuerstein T; Malik Z
Photochem Photobiol Sci; 2011 Aug; 10(8):1310-7. PubMed ID: 21655622
[TBL] [Abstract][Full Text] [Related]
15. Silencing of ALA dehydratase affects ALA-photodynamic therapy efficacy in K562 erythroleukemic cells.
Feuerstein T; Schauder A; Malik Z
Photochem Photobiol Sci; 2009 Oct; 8(10):1461-6. PubMed ID: 19789817
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.
Marcus SL; Sobel RS; Golub AL; Carroll RL; Lundahl S; Shulman DG
J Clin Laser Med Surg; 1996 Apr; 14(2):59-66. PubMed ID: 9484077
[TBL] [Abstract][Full Text] [Related]
17. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
[TBL] [Abstract][Full Text] [Related]
19. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
20. Potential efficacy of a delta 5-aminolevulinic acid thermosetting gel formulation for use in photodynamic therapy of lesions of the gastrointestinal tract.
Bourre L; Thibaut S; Briffaud A; Lajat Y; Patrice T
Pharmacol Res; 2002 Feb; 45(2):159-65. PubMed ID: 11846630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
